Psychiatric NP Scope of Practice for Depression in Michigan

If you’re a psychiatrist or PMHNP treating depression via telehealth, you’re navigating one of the most fluid regulatory landscapes in healthcare right now. The good news? The rules are moving in your favor. The challenge? Keeping up with what’s actually required versus what used to be required, especially when it comes to prescribing controlled substances and practicing across state lines.

Let me walk you through what matters for your practice in 2025–2026 — the federal DEA rules that just got extended (again), how your scope of practice varies wildly by state if you’re a PMHNP, and what the major states like California, Texas, Florida, New York, Pennsylvania, and Illinois actually allow you to do when treating depression patients remotely.

The Big Picture: DEA Just Extended Telehealth Prescribing Through 2026

Here’s what you need to know first: You can still prescribe controlled substances via telehealth without ever seeing the patient in person, thanks to the DEA’s fourth temporary extension announced in January 2026. This keeps the COVID-era flexibilities alive through December 31, 2026.

Why does this matter for depression care? Most antidepressants aren’t controlled substances — your SSRIs, SNRIs, bupropion, mirtazapine, etc. are all Schedule-free and have never been restricted by federal telehealth rules. But psychiatric practice is rarely that simple. Your patient with major depression often has comorbid anxiety (might need a benzodiazepine), treatment-resistant symptoms (might need stimulant augmentation), or ADHD (definitely needs a stimulant). Those are Schedule II–IV controlled substances, and until COVID, the Ryan Haight Act said you couldn’t prescribe them via telehealth without at least one in-person exam first.

The Ryan Haight Act (21 USC §829(e)) was passed in 2008 to stop online ‘pill mills’ from shipping opioids to people who just filled out a web form. It mandated an in-person medical evaluation before any controlled substance could be prescribed via telemedicine. During the COVID public health emergency, that requirement was suspended. When the PHE ended in May 2023, the DEA could have snapped the old rules back into place — which would have cut off millions of patients mid-treatment. Instead, they’ve issued four consecutive temporary extensions (through 2023, 2024, 2025, and now 2026), buying time to finalize permanent rules.

What this means for you today: You can initiate Adderall for a new ADHD patient, prescribe Klonopin for panic disorder comorbid with depression, or manage any other Schedule II–V medication entirely via video visit, as long as you’re following standard of care and state law. No federal in-person exam required through the end of 2026.

What’s Coming: DEA’s Proposed Permanent Rules

The DEA isn’t going to extend these flexibilities forever. On January 16, 2025, they announced three proposed rules to create a permanent framework for telehealth prescribing:

1. Special Registration for Telemedicine (Schedules III–V): Any provider who wants to prescribe Schedule III–V controlled substances via telehealth would apply for a special DEA telemedicine registration. This is the mechanism Congress envisioned back in 2008 but DEA never implemented until now.

2. Advanced Telemedicine Prescribing Registration (Schedule II): Here’s the big one for psychiatrists. DEA proposes creating an ‘Advanced Telemedicine Prescribing’ registration specifically for board-certified psychiatrists (plus a few other specialties like hospice/palliative care and nursing home physicians) that would allow Schedule II prescribing via telehealth without an in-person visit. This essentially codifies what you’re doing now under the temporary rules — but it would require you to obtain this special registration and likely meet certain standards (DEA is still taking comments on what those should be).

3. Platform Registration Requirements: DEA also wants to require telehealth companies and platforms to register with DEA and meet new standards to prevent the ‘pill mill’ abuses that emerged during COVID (a few telehealth startups prescribed tens of thousands of stimulants with minimal oversight, which is part of why DEA is being careful here).

For PMHNPs: The proposed rule text mentions ‘psychiatrists’ for the Schedule II advanced registration but doesn’t explicitly include nurse practitioners. This could mean PMHNPs might not qualify for independent Schedule II telehealth prescribing under the permanent rules — or it might be clarified during the rulemaking process. Right now, under the temporary extension, PMHNPs can prescribe Schedule II via telehealth in states where their scope allows it. But if the final rule excludes NPs, you’d need to either have a collaborating psychiatrist with the registration or see the patient in person first for Schedule II prescribing after 2026.

Bottom line: The regulatory trend is toward permanent telehealth flexibility for psychiatric prescribing, but with more structure than the ‘anything goes’ COVID era. Psychiatrists will likely maintain broad telehealth prescribing authority; PMHNPs should monitor how the final rules treat APRN scope.

The Economics of Telehealth Prescribing

One reason the DEA extensions matter so much: they preserve the economic viability of telepsychiatry. When you can evaluate and prescribe for a new patient entirely via video, you eliminate geographic barriers and dramatically expand your potential patient base.

For providers considering telehealth platforms like Klarity, the economics are straightforward: instead of spending thousands per month on marketing (SEO takes 6–12 months and $3,000–5,000/month to generate meaningful patient flow; Google Ads for mental health keywords run $15–40+ per click with conversion costs of $200–400+ per booked patient), you pay a standard per-appointment fee for pre-qualified patients who are already matched to your specialty and availability.

No upfront marketing spend. No wasted ad spend on clicks that don’t convert. No monthly subscription fees regardless of patient volume. You control your schedule and only pay when you actually see a patient — that’s guaranteed ROI versus gambling on marketing channels that might not work.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Scope of Practice: What Can You Actually Prescribe?

Psychiatrists (MD/DO)

Your scope is simple: everything. You can diagnose and treat depression, prescribe any medication (controlled or not), and practice independently in all 50 states. The only requirements are:

• State medical license where the patient is located
• DEA registration in that state (for controlled substances)
• Following standard of care (thorough evaluation, documentation, informed consent, suicide risk assessment, etc.)

No supervision requirements. No collaborative agreements. No restrictions on what you can prescribe as long as it’s medically appropriate.

The only medication-specific limitation worth noting is esketamine (Spravato) for treatment-resistant depression — it’s Schedule III, but FDA requires it be administered in a certified clinic under supervision due to dissociative effects and abuse potential. You can do the psychiatric evaluation via telehealth, but the patient needs to go to a REMS-certified site for the actual nasal spray administration.

Psychiatric Mental Health Nurse Practitioners (PMHNPs)

Your scope depends entirely on which state you’re practicing in. The training is the same — you’re fully qualified to diagnose and treat depression — but state nurse practice acts create wildly different practice environments:

Full Practice Authority States (California, New York, Illinois):

• California (AB 890): As of January 2024, experienced PMHNPs (3+ years, national certification) can practice completely independently as ‘104 NPs’ within their population focus. No physician oversight, no collaborative agreement required. You can open your own telepsychiatry practice, diagnose depression, prescribe all medications including controlled substances, and manage patients autonomously. This is a recent change — California was historically a restricted state until AB 890 phased in between 2023–2024.

• New York: After completing 3,600 hours of supervised practice, PMHNPs can practice without a written collaborative agreement or physician supervision (law changed in 2022, making permanent what was a temporary COVID provision). An experienced PMHNP in New York essentially has the same practice authority as a psychiatrist for managing depression patients.

• Illinois: PMHNPs can apply for Full Practice Authority (FPA) after completing 4,000 hours of collaborative practice plus additional pharmacology education (45 hours CE). With FPA, you can prescribe independently, including Schedule II controlled substances (with a consultation requirement for extended Schedule II opioid prescriptions, which rarely applies to psychiatric practice). Illinois has had this pathway since 2017; thousands of APRNs now practice with FPA.

Restricted Practice States (Texas, Florida, Pennsylvania):

• Texas: All APRNs must have a written Prescriptive Authority Agreement with a physician. The supervising physician must be available for consultation and you’re required to meet monthly to discuss complex cases. You cannot practice independently, period. The physician doesn’t need to co-sign every prescription or attend your telehealth sessions, but they must be actively involved in overseeing your practice. Legislation to grant NP independence has failed repeatedly in Texas.

• Florida: Only ‘primary care’ NPs (family medicine, pediatrics, internal medicine) can practice autonomously under Florida’s 2020 law. Psychiatric NPs were explicitly excluded — you must have a supervising physician and a signed protocol on file with the Board of Nursing. This means even if you have 20 years of experience, you cannot practice independently in Florida as a PMHNP.

• Pennsylvania: PMHNPs must maintain a collaborative agreement with a physician to prescribe. Bills to grant NP independence have stalled in the legislature multiple times. The collaboration doesn’t require the physician to be present for patient visits, but they must be available and the scope of collaboration must be documented.

Prescribing Authority Details

Psychiatrists: Full prescribing authority for Schedules II–V and all non-controlled medications. Must have DEA registration in each state of practice.

PMHNPs in Full Practice States: Can prescribe all schedules after obtaining DEA registration and meeting state requirements (like Illinois’s pharmacology CE). Some states have minor caveats (Illinois requires physician consultation for extended Schedule II opioid prescriptions; California requires checking PDMP for controlled substances).

PMHNPs in Restricted States: Prescribing authority is delegated through the collaborative agreement. Many states allow Schedule III–V prescribing with minimal physician involvement, but Schedule II is often more restricted. Texas, for example, limits NP Schedule II prescribing to hospital-based or hospice settings — an outpatient PMHNP in Texas generally cannot prescribe Adderall independently, even with a collaborative agreement.

For depression treatment specifically: Most of what you prescribe day-to-day (SSRIs, SNRIs, bupropion, buspirone, trazodone, antipsychotics, mood stabilizers) is non-controlled, so scope differences mainly affect your ability to manage comorbid conditions like ADHD (stimulants), anxiety (benzodiazepines), or insomnia (controlled sleep aids).

State-by-State Telehealth Prescribing Rules

Federal DEA rules set the floor, but states can add requirements. Here’s what matters in the major markets:

California

Telehealth Prescribing: No state-specific in-person exam requirement. Telehealth encounters are held to the same standard of care as in-person, meaning if you can reasonably diagnose and treat via video, you can prescribe. California explicitly allows controlled substance prescribing via telehealth, consistent with federal rules.

During COVID: California even allowed audio-only telehealth for mental health (video preferred when possible, but phone acceptable if video isn’t feasible). This flexibility has largely continued for behavioral health.

PMHNP Independence: AB 890 created the pathway for independent practice. As of 2024, experienced PMHNPs can practice without physician supervision — a huge shift for California. The state has telehealth parity laws requiring insurers to cover tele-mental health equivalently to in-person.

Licensing: California is not in the Interstate Medical Licensure Compact (IMLC), so out-of-state psychiatrists must obtain a full California medical license to treat California patients. No shortcuts.

Key requirement: Must check California’s PDMP (CURES) when prescribing controlled substances.

Texas

Telehealth Prescribing: Texas reformed its telehealth laws in 2017 (SB 1107), eliminating the prior requirement for an in-person visit before telehealth. A valid practitioner-patient relationship can now be established via live audio-visual telemedicine. Video is required for new patients — phone-only is insufficient under Texas Medical Board rules.

The chronic pain exception: Texas law prohibits treating chronic pain with controlled substances via telemedicine unless stringent conditions are met (like prior in-person exam within 90 days, documented medical necessity, etc.). This primarily affects pain management and primary care. For psychiatric practice, it means you should be cautious if a depression patient also has chronic pain requiring opioids or benzodiazepines — you may need an in-person component for that aspect of care.

Prescribing for depression/ADHD/anxiety: No state-level prohibition beyond the chronic pain rule. You can prescribe stimulants for ADHD, benzodiazepines for panic disorder, etc., via video visit as long as it’s not primarily for chronic pain management.

PMHNP Practice: Texas requires all APRNs to have a Prescriptive Authority Agreement with a physician. Monthly meetings and chart reviews are expected. No independent practice allowed. If you’re a PMHNP joining a telehealth platform for Texas patients, you’ll need a supervising Texas-licensed physician involved in your practice structure.

Licensing: Texas participates in the IMLC for physicians, making it easier to obtain a Texas license if you’re already licensed elsewhere and meet compact eligibility. Must have full Texas license — they eliminated their out-of-state telemedicine registration option.

Florida

Out-of-State Telehealth Registration: Florida Statute §456.47 allows out-of-state providers to register to provide telehealth services to Florida patients without obtaining a full Florida license (must renew every two years). This is unusual and has made Florida a popular telehealth market.

The Schedule II Psychiatric Exception: Here’s where Florida gets interesting. State law prohibits prescribing Schedule II controlled substances via telehealth — except for four specific exceptions: (1) psychiatric disorders, (2) inpatient hospital treatment, (3) hospice care, or (4) nursing home residents.

For depression providers, the psychiatric disorder exception is your green light. You can prescribe Adderall, Ritalin, Vyvanse, or any other Schedule II medication via telehealth to a Florida patient as long as it’s part of treating a psychiatric condition. Document the psychiatric diagnosis (major depression, ADHD, treatment-resistant depression, etc.) clearly in your records.

Schedule III–V medications can be prescribed via telehealth without restriction (so benzodiazepines, Ambien, etc., are straightforward).

PMHNP Practice: Florida’s 2020 NP autonomy law excluded psychiatric mental health NPs from independent practice. You must have a supervising physician and a signed protocol on file with the Board of Nursing. Even if you have the out-of-state telehealth registration, you need a Florida-licensed psychiatrist formally supervising your practice.

Key requirement: Check Florida’s PDMP (E-FORCSE) before prescribing controlled substances. Obtain patient consent for telehealth services and verify patient identity.

New York

Telehealth Prescribing: No state-specific barriers. New York encourages telehealth for mental health access and has had insurance parity laws for years. During COVID, New York explicitly allowed audio-only telehealth for mental health (many of these provisions have been extended administratively).

PMHNP Independence: After 3,600 hours of practice, PMHNPs can practice without a written collaborative agreement or physician oversight (law made permanent in 2022). This means an experienced PMHNP in New York has nearly identical practice authority to a psychiatrist for managing depression.

Controlled Substances: New York follows federal rules; no additional state restrictions. Electronic prescribing is mandatory for controlled substances (New York has required e-prescribing for all medications since 2016, with limited exceptions).

Licensing: Must have full New York license. New York is not in the IMLC for physicians and does not offer an out-of-state telehealth registration option.

Practice environment: New York is progressive on telehealth and mental health access. State authorities actively support tele-mental health to reach underserved upstate communities. Large health systems (like NYU Langone, Northwell) have robust telepsychiatry programs.

Pennsylvania

Telehealth Law: Pennsylvania doesn’t have a comprehensive telehealth statute (several attempts have failed). Instead, the Department of State issued guidance confirming that licensed professionals can provide services via telemedicine as long as it meets the standard of care. This is less prescriptive than other states but functionally allows telehealth prescribing.

Controlled Substances: Pennsylvania defers to federal rules. No state prohibition on tele-prescribing controlled substances beyond requiring electronic prescribing for Schedules II–V (with limited exceptions for technological failures or hospice).

PMHNP Practice: Collaborative agreement with a physician required. No full practice authority legislation has passed. The physician doesn’t need to attend telehealth sessions, but must be available for consultation and the agreement must be on file with the Board of Nursing.

Licensing: Pennsylvania joined the IMLC for physicians in 2021, which streamlines out-of-state psychiatrists obtaining a Pennsylvania license. Must have full PA license; no special telehealth registration exists.

Key requirements: Obtain explicit patient consent for telehealth (document it). Check Pennsylvania’s PDMP for controlled substances. Follow best practices for emergency protocols (know how to activate local emergency services if a patient is in crisis during a tele session).

Practice environment: Pennsylvania has significant rural areas with severe psychiatrist shortages. Telepsychiatry is critical for serving these communities. State Medicaid reimburses telehealth equivalently to in-person for behavioral health.

Illinois

Telehealth Law: Illinois passed comprehensive telehealth legislation in 2021 (Public Act 102-104) requiring insurance parity and protecting the right to use telehealth from any location. No in-person exam requirement; telehealth evaluation is valid for prescribing if it meets standard of care.

PMHNP Independence: Full Practice Authority available after 4,000 hours of collaborative practice plus additional education/training (45 hours of pharmacology CE in specialty area). APRNs with FPA can prescribe all schedules independently, though there’s a consultation requirement with a physician for extended Schedule II opioid prescriptions (rarely applies to psychiatric practice).

Controlled Substances: Illinois aligns with federal law; no state prohibition. APRNs with FPA must obtain their own Illinois controlled substance license and DEA registration to prescribe controlled medications.

Licensing: Must have Illinois license (physicians or APRNs). Illinois is in the IMLC for physicians. Illinois enacted an APRN Compact in 2023, but it won’t be active until more states join.

Key requirement: Use Illinois Prescription Monitoring Program (PDMP) for controlled substances. Electronic prescribing is mandatory for controlled substances (with standard exceptions).

Practice environment: Illinois has strong regulatory support for telehealth expansion. Most psychiatrists are in Chicago/Springfield, leaving downstate Illinois underserved — telepsychiatry fills this gap. The state government has funded initiatives to integrate tele-mental health in community health centers.

Practical Compliance Checklist

Federal Requirements (All States):

• [ ] Valid DEA registration in each state where patients are located
• [ ] Following standard of care (thorough evaluation, documentation, informed consent)
• [ ] Suicide risk assessment documented for depression patients
• [ ] Patient consent for telehealth services obtained
• [ ] Secure, HIPAA-compliant video platform
• [ ] Emergency protocols in place (how to activate local emergency services if patient is in crisis)

State-Specific Requirements:

• [ ] Active medical license or APRN license in patient’s state (or valid telehealth registration where applicable, like Florida)
• [ ] PMHNP collaborative agreement on file (if required in that state)
• [ ] PDMP check before prescribing controlled substances (all states now have PDMPs; most require checking)
• [ ] Electronic prescribing for controlled substances (required in most states: PA, IL, NY, others)
• [ ] Patient identity verification (particularly emphasized in FL, CA)
• [ ] Documentation of psychiatric diagnosis when prescribing Schedule II (especially important in FL due to the psychiatric disorder exception)

The Business Case for Telehealth Platforms

Here’s the reality of building a telehealth practice independently: acquiring a qualified psychiatric patient through DIY marketing typically costs $200–500+ when you factor in all costs:

• Agency or consultant fees for SEO/PPC management
• Ad spend testing and optimization (mental health keywords are expensive: $15–40+ per click on Google Ads)
• Staff time to handle and qualify leads
• No-show rates from cold leads who aren’t pre-screened
• 6–12 months of SEO investment before meaningful results
• Failed campaigns and wasted budget

SEO takes at least six months of consistent investment before generating patient flow, and most solo providers don’t have the expertise or patience for this. Google Ads conversion rates for mental health are notoriously low — you might pay $15–40 per click, and most clicks don’t convert to booked patients. Realistic cost per booked patient through PPC is $200–400+.

Directory listings (Psychology Today, Zocdoc) charge monthly fees AND you compete with hundreds of other providers on the same page. Zocdoc charges per booking ($35–100+), but when you add the monthly subscription, it adds up fast.

Platforms like Klarity use a pay-per-appointment model similar to Zocdoc, but with key differences:

• No upfront marketing spend or monthly subscription fees
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients

Instead of spending $3,000–5,000/month on marketing with uncertain results, you pay a standard per-appointment fee only when a qualified patient books with you. That’s guaranteed ROI versus gambling on marketing channels that might take months to work (or might not work at all).

For providers starting out or scaling up, a platform that handles patient acquisition removes the risk entirely. You can focus on clinical care while the platform handles marketing, patient matching, scheduling infrastructure, and telehealth technology.

What’s Next: Monitoring the Regulatory Landscape

Through 2026: Current DEA flexibilities remain in place. Practice as you are now, but prepare for potential changes.

Late 2026: DEA expected to finalize permanent telehealth rules. Key things to watch:

• Whether psychiatrists will need the ‘Advanced Telemedicine Prescribing’ special registration for Schedule II
• Whether PMHNPs will be included in Schedule II telehealth prescribing authority
• What requirements will apply to telehealth platforms (may affect which platforms you can work with)
• Whether any new consultation or follow-up requirements will be imposed

State-Level Trends:

• More states likely to grant NP full practice authority (several states have bills pending in 2025)
• Continued expansion of telehealth parity in insurance (nearly universal now, but ongoing fine-tuning)
• Possible new state telehealth regulations in PA, where formal rules have been under development

What You Should Do:

1. Join professional organizations that monitor regulatory changes (APA for psychiatrists, AANP for PMHNPs) — they’ll notify members of major rule changes

2. Subscribe to DEA updates if you prescribe controlled substances via telehealth

3. Check state medical/nursing board websites periodically for telehealth guidance updates

4. Document thoroughly — if rules change, good documentation of your evaluation process protects you

5. Consider multi-state licensing now if you’re interested in expanding your telehealth practice (IMLC for physicians, nurse licensure compacts for APRNs where applicable)

Frequently Asked Questions

Can I prescribe antidepressants via telehealth to a patient I’ve never met in person?

Yes. Non-controlled antidepressants (SSRIs, SNRIs, bupropion, mirtazapine, trazodone, etc.) have never been restricted by federal telehealth rules. As long as you conduct an appropriate evaluation via video and it meets the standard of care, you can prescribe. State law may require that you obtain patient consent for telehealth and document your evaluation, but no state currently prohibits this.

Can I prescribe Adderall or other Schedule II stimulants via telehealth?

Yes, through December 31, 2026, under the DEA’s temporary extension. After that, it depends on the final DEA rules. The proposed rules would allow psychiatrists to obtain an ‘Advanced Telemedicine Prescribing’ registration for Schedule II prescribing via telehealth. PMHNPs should monitor whether they’ll be included in that pathway — current proposal lists psychiatrists specifically. Some states have additional rules (Florida’s psychiatric disorder exception explicitly allows it; Texas has no specific prohibition for psychiatric Schedule II prescribing).

What about benzodiazepines for anxiety comorbid with depression?

Benzodiazepines are Schedule IV, so they’re covered under the current DEA telehealth extension and would likely be covered under the proposed ‘Special Registration for Telemedicine’ (Schedules III–V) going forward. You can prescribe them via telehealth now. Just follow standard of care: document the anxiety diagnosis, assess for substance use risk, discuss risks/benefits with the patient, and check your state’s PDMP.

Do I need malpractice insurance that covers telehealth?

Yes. Most malpractice policies now cover telehealth, but check with your carrier. Some older policies had telehealth exclusions that may need to be updated. If you’re practicing in multiple states via telehealth, ensure your coverage extends to all states where you’re licensed.

Can I use my home office for telehealth visits?

Yes, as long as you’re using a HIPAA-compliant platform and maintaining patient privacy. Make sure no one can overhear your sessions and your background is professional. Some states (like California) have specific guidance about ensuring the patient’s privacy on their end too — you should ask the patient if they’re in a private space where they can speak freely.

What if a patient is acutely suicidal during a telehealth session?

You should have emergency protocols in place before this happens:

• Obtain emergency contact information from every patient at intake
• Know the patient’s physical location for each session (address, ideally with nearest cross street)
• Have a plan for how to activate local emergency services (911 or crisis mobile team)
• Document your emergency protocol and that you discussed it with the patient
• If a patient is acutely suicidal and won’t agree to go to an emergency room, you may need to initiate an involuntary evaluation — know how this works in the state where the patient is located (some states allow telehealth providers to initiate this; others require an in-person evaluation)

Most states recommend providers establish relationships with local crisis resources in the areas where they treat patients frequently.

If I’m a PMHNP in a restricted-practice state, can I still do telehealth?

Yes, but you need a collaborative agreement with a physician in that state. The physician doesn’t need to be present for your telehealth sessions, but they must be available for consultation and the agreement must meet state requirements. Some telehealth platforms (like Klarity) can help connect you with collaborating physicians in states where it’s required.

Can I treat patients in multiple states?

Yes, but you must be licensed in each state where your patients are located at the time of the telehealth visit. If a patient travels to another state, technically they need to be in a state where you’re licensed for that session (or you need to refuse the session). Interstate compacts (IMLC for physicians, APRN Compact for nurses where active) can streamline getting licensed in multiple states.

What happens if the DEA doesn’t finalize permanent rules by the end of 2026?

Based on the pattern of the past few years, DEA would likely issue another extension rather than cut off millions of patients mid-treatment. However, you should have a contingency plan: know which of your patients are on controlled substances that were initiated via telehealth, and if necessary, arrange for them to have an in-person evaluation or transition to a local provider.

Ready to Start or Scale Your Telehealth Practice?

The regulatory environment for telepsychiatry is more favorable now than it’s ever been — and likely to stay that way. Whether you’re a psychiatrist with full prescribing authority or a PMHNP navigating state-specific scope rules, telehealth opens up your patient base beyond geographic limits.

If you’re tired of the DIY marketing treadmill (or the idea of spending thousands per month hoping SEO eventually works), Klarity Health offers a straightforward alternative: you get pre-qualified patients matched to your specialty, a built-in telehealth platform, and you only pay when you actually see a patient.

No marketing budget. No wasted ad spend. No uncertainty.

Join Klarity’s provider network and start seeing patients on your schedule, with the compliance infrastructure and patient acquisition handled for you. Whether you’re looking to build a full-time telehealth practice or add remote patients to your existing schedule, we’ve built a platform that works with the regulations (not against them) to help you grow.

Citations & Sources

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026’ (January 2, 2026) – www.hhs.gov

2. DEA Press Release – ‘DEA Announces Three New Telemedicine Rules to Continue Open Access to Care’ (January 16, 2025) – www.dea.gov

3. Florida Statutes §456.47 – ‘Use of Telehealth to Provide Services’ (Florida Legislature, 2019 with updates through 2025) – www.leg.state.fl.us

4. Texas Administrative Code Title 22, Part 9 §174.5 – ‘Telemedicine Issuance of Prescriptions’ (Texas Medical Board, updated January 15, 2025) – txrules.elaws.us

5. California AB 890 Implementation – California Board of Registered Nursing (updated January 2023) – www.rn.ca.gov

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,disruptions%20in%20care%20while%20permanent
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=registration%20is%20available%20to%20medical,V%20medications
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=These%20rules%20are%20a%20result,temporary%20rule%20until%20December%202025
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=is%20accessible%20for%20medical%20care,is%20being%20prescribed%20controlled%20medication
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%20law%20previously%20allowed,based%20on%20only
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,person%20setting
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,be
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=telehealth%20to%20provide%20health%20care,in%20Schedule%20II%20of%20s
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,through%20a%20telemedicine%20medical%20service